Jane Street Group, LLC Novo Cure LTD Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Jane Street Group, LLC holds 95,247 shares of NVCR stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,247
Previous 99,999
4.75%
Holding current value
$2.51 Million
Previous $1.71 Million
13.08%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
76.9MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$319 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$312 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$209 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$113 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$79.8 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.76B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...